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Background: Uterine rupture classically presents with severe abdominal pain, loss of fetal station, vaginal bleeding,
and shock.
Case presentation: We present a case of uterine rupture presenting as significant urinary retention that occurred
following a second trimester abortion induced with mifepristone and misoprostol. Uterine rupture was discovered
unexpectedly on diagnostic laparoscopy. The uterine rupture was contained by dense adhesions between the
omentum and bladder with the previous uterine cesarean hysterotomy scar.
Conclusion: This case highlights the difficulties in diagnosis of abnormal placentation and an unusual presentation
of uterine rupture. This case was managed successfully laparoscopically.
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Second trimester pregnancy termination is a common
gynecologic procedure and may be performed by surgi-
cal evacuation or induction of labor. Both surgical
evacuation and induction of labor are safe and have rare
complications including infection, blood loss, uterine
rupture or perforation. Misoprostol is a synthetic prosta-
glandin E1 analogue which is widely used for induction
of labor and is an effective agent for second trimester
abortion [1]. Retrospective analysis has shown that
mifepristone combined with a prostaglandin analogue in
second trimester abortion is not associated with higher
morbidity in women with a prior cesarean section [2]. A
rare complication of second trimester induction of labor
with a previous uterine scar is uterine rupture, which
most commonly presents with abdominal pain, loss of
fetal station, vaginal bleeding, and shock [3]. Here, we
present an interesting case of uterine rupture during a* Correspondence: yanglw1967@163.com
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unless otherwise stated.second trimester abortion after oral administration of
mifepristone and misoprostol. The patient presented
with idiopathic fever and urinary retention, and the uter-
ine rupture was diagnosed unexpectedly during explora-
tory laparoscopy.
Case presentation
A 31-year-old multigravid woman with a history of a
prior low transverse cesarean delivery presented to a
family planning clinic at 16 weeks gestation for elective
termination of pregnancy. Her obstetric history was sig-
nificant for a prior cesarean section performed six years
prior. Her past medical and surgical history was other-
wise unremarkable. A transabdominal ultrasound per-
formed on the day of admission confirmed a fetus of
16 week gestation with an anterior placenta. In order to
further delineate the relationship between the uterine
scar and the placenta, an abdominal MRI was per-
formed. The MRI demonstrated an unclear uterine scar
near the placental implantation site. The patient was
counseled on risks associated with abnormal placenta-
tion and was offered uterine artery embolization, dilation
and evacuation and hysterotomy. The patient, however,
decided to proceed with induction of labor for termin-
ation. The termination of her pregnancy was approvedhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 2 A patch of placenta adhered to the rupture and
lower uterine segment was observed when the omentum
majus removed.
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Hospital. A written informed consent was obtained from
this patient before the procedure.
Termination was performed with a loading dose of
50 mg of oral mifepristone (RU486) followed by 25 mg
administered every 12 hours until a total of 300 mg had
been administered. Following completion of mifepris-
tone, misoprostol was administered at a dose of 200 ug
orally every hour. The patient received a total of 1200 ug
of misoprostol. She had an unremarkable vaginal deliv-
ery with spontaneous delivery of the placenta. Vaginal
bleeding was minimal. Four hours after the procedure
the patient developed a fever of 38.5°C, but denied fur-
ther symptoms. The patient’s temperature resolved
spontaneously by the next morning without interven-
tion. On post procedure day 1, the patient complained
of abdominal distention and dysuria. A urethral catheter
was inserted and 800 ml of clear urine was drained. A
pelvic ultrasound was performed and demonstrated a
32 x 25 mm abnormal radiodensity at the anterior
uterine wall with an unclear boundary at the anterior
cervical wall, concerning for retained products of con-
ception versus placenta accreta. Methotrexate was ad-
ministered. Given the idiopathic urinary retention and
abnormal findings on ultrasound, laparoscopic explor-
ation was performed to evaluate for placental growth
into in bladder.
At the time of diagnostic laparoscopy, no hemoperito-
neum was noted; however, there were significant adhe-
sions between the omentum and anterior abdominal
wall. Unexpectedly, a uterine rupture at the lower uter-
ine segment was observed when the pelvic organs were
restored to their normal anatomy. There was a 1.5 cm
length anterior wall uterine rupture along the left por-
tion of the previous scar (Figure 1). Moreover, a portion
of the placenta was found to be adherent to the uterus
at the site of the rupture when the omentum was re-
moved (Figure 2). The bladder was firmly adherent toFigure 1 A length of 1.5 cm anterior wall uterine rupture along
the left previous scar was found. The rupture was filled with small
amounts of placenta and omentum majus.the uterine scar and rupture, and urology was consulted
to assist in separating the bladder from the uterus.
Dilatation and curettage was performed under direct
laparoscopic visualization and the specimens were
confirmed to be placenta by postoperative pathology
examination (Figure 3). An ultrasound was performed
to ensure no residual placental tissue was present. The
uterine dehiscence was repaired laparoscopically. The
entire procedure was performed using minimally inva-
sive techniques.
Discussion
Misoprostol has been widely used for medical abortion.
Mifepristone has also been reported to be relatively safe
and effective for use in the second trimester [4,5]. Ac-
cording to the recent clinical guidelines published by the
Society of Family Planning (#2013-4), misoprostol is
widely used as an off-label alternative or adjunct to os-
motic dilators prior to dilation and evacuation in women
desiring a second trimester pregnancy termination [6]. It
is also safely used for labor-induction in mid second tri-
mester abortions, even in women with prior uterine sur-
gery [7]. A recent systematic review reported that theFigure 3 Specimens sent for pathological examination were
confirmed to be placenta.
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0.3% [3].
Uterine rupture is a rare but serious complication of
second trimester induction of labor. Severe lower ab-
dominal pain and shock caused by intraabdominal
hemorrhage is the classic clinical presentation [8]. This
patient, however, presented insidiously with urinary re-
tention. The patient’s vital signs were clinically stable,
and she reported no symptoms of abdominal pain. The
ultrasound and MRI performed before the abortion
raised concerns for abnormal placentation. The presen-
tation of urinary retention raised concern for abnormal
placentation with potential bladder involvement, al-
though the patient had no evidence of hematuria,
Methotrexate was administered timely to induce ne-
crosis of trophocytes. Laparoscopic exploration was
performed before dilatation and curettage to evaluate
for bladder involvement. The uterine rupture was an
unsuspected finding during the operation. The rupture
was contained within the vesicouterine space, leaving
only a small hole obscured by omental adhesions. Al-
though it is unclear when the uterine scar dehisced,
we suspect that this occurred prior to delivery given
the dense adhesions, and further developed to uterine
rupture with labor. Previous reports have noted simi-
lar findings of second trimester uterine rupture in the
setting of abnormal placentation. This case was suc-
cessfully managed laparoscopically. There is only one
previous case report has described repair of uterine
rupture with laparoscopic techniques [9].
Conclusions
In summary, this is an unusual case of uterine rupture
presenting with a primary complaint of urinary reten-
tion. This case highlights the difficulties in diagnosis of
abnormal placentation and an unusual presentation of
uterine rupture. Following a second trimester abortion,
uterine rupture should be included in the differential
diagnosis for patients presenting with urinary retention
and continued vaginal bleeding. This case was success-
fully managed with laparoscopy. Minimally invasive
surgery can be performed safelyy following a second
trimester abortion and should be considered for man-
agement of complications following elective second
trimester abortion.
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